Aoxing Pharmaceutical (AXN) Reports Q1 EPS of $0.02
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/2/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- DataMeds AI's Corexa Pharmacy tops $1M in monthly revenue
- Equities rebound to close higher as surging Treasury yields recede
- onsemi cuts Synaptics deal price to $5.7B after rival bid
- Wells Fargo names 13 stocks as overweight tactical ideas
- Twilio, Vylor set to join S&P 500 as index reshuffles members
Aoxing Pharmaceuticals Q1 Revenue Up 92 Percent; Net Income Of $1.35 Million
November 13, 2015 8:30 AM ESTJERSEY CITY, N.J., Nov. 13, 2015 /PRNewswire/ --Â Aoxing Pharmaceutical Company, Inc. (NYSE MKT: AXN) today announced that, for the first quarter of fiscal 2016 ended September 30, 2015, the company achieved revenue of $8,744,822, a 92 percent improvement on revenue of $4,565,081 recorded in the same quarter in fiscal 2015.
The company's net income in Q1 fiscal 2016 was $1,348,433, or .02 per share, compared to a net loss of $2,405, or $(.00) per share, in like year-ago quarter.
Weighted average number of shares outstanding was 69,852,302 for Q1 fiscal 2016 and 53,098,267 for Q1 fiscal 2015.
Aoxing's cash balance as of September 30, 2015 was $8,171,875, compared to... More
